Fig. 2. Overexpression of miR302-367 cluster in the developing heart results in increased cardiomyocyte proliferation and cardiomegaly. Overexpression.

Slides:



Advertisements
Similar presentations
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Human Ventricular Unloading Induces Cardiomyocyte.
Advertisements

Expression of CD36 and psap in a TMA of human ovarian cancer patients
Fig. 2 STED microscopy of isolated cardiomyocytes from mice treated with MP-rhodamine–loaded CaPs. STED microscopy of isolated cardiomyocytes from mice.
Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation.
Soft robotic device applied to the left side in a coronary ligation HF model. Soft robotic device applied to the left side in a coronary ligation HF model.
Fig. 6 Transmissibility of adiposity from humanized mice to germ-free recipients. Transmissibility of adiposity from humanized mice to germ-free recipients.
Fig. 1. Bj mutant exhibits outflow tract malalignment defects.
Fig. 8. The cohort of 3KO/CCS-LacZ embryos that survived to later timepoints showed marked hyperplasia of the ventricular conduction system (A–F).(B) Severe.
Fig. 1 Characterization of decellularized zECM.
Fig. 2. Spontaneous inflammasome activation by pyrin S242R.
Fig. 5 Quantitative assessment of the efficacy of the tissue-engineered implant to heal the TMJ disc defect. Quantitative assessment of the efficacy of.
Fig. 1. Generation of the ΔEx50 mouse model.
Fig. 1 ZIKV RNA in blood and tissues.
Consolidated Standards of Reporting Trials flow diagram of VRC trial
Fig. 3 The electrical contact of direct-printed and reconfigured liquid metals. The electrical contact of direct-printed and reconfigured liquid metals.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Filipin staining of marginal gyrus of cerebral cortex in NPC cats
Fig. 5. Microarray analysis of tumors treated by dabrafenib, trametinib, or the combination of dabrafenib and trametinib with pmel-1 ACT or mock ACT. Microarray.
Fig. 5. Mutant KRAS increases HR capacity and MEKi decreases HR capacity in RAS mutant cells, causing increased DNA damage. Mutant KRAS increases HR capacity.
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
Fig. 3. Comparison of prediction performance.
Fig. 6. TIV-09, but not MIV-09, induces an IFN signature in the blood of vaccinated individuals at day 1. TIV-09, but not MIV-09, induces an IFN signature.
Fig. 4. The effect of combined inhibition of BCL-2 and BCR-ABL on leukemia LT-HSC frequency. The effect of combined inhibition of BCL-2 and BCR-ABL on.
Soft robotic device applied to the left side in a coronary ligation HF model. Soft robotic device applied to the left side in a coronary ligation HF model.
Fig. 2. Deficiency of neuronal HS leads to reduced neuroinflammation.
Fig. 1. Value proposition. Value proposition.Summarized are the valuation estimates (log scale), from panel members (selected by A.W.L.) for the NCATS.
Autophagy protein abundance, but not autophagy flux, is altered in Cnot3-depleted heart. Autophagy protein abundance, but not autophagy flux, is altered.
Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.
Fig. 5. Col IV–Ac2-26 NPs decrease lesion area, necrotic area, and oxidative stress in brachiocephalic arterial plaques. Col IV–Ac2-26 NPs decrease lesion.
Colonization in tumor models and different modes of administration
Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.
HECTD2 knockdown ameliorates Pseudomonas-induced lung injury in vivo
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
BMS blocks functional responses in primary immune cells driven by IFNα
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
The microchip-based drug delivery device and overview of study design
Fig. 5. Octet BLI competition assay using D25 and motavizumab.
Fig. 6. C3 deficiency resulted in partial sparing of neuron loss in hippocampal CA3 in 16-month-old APP/PS1 mice. C3 deficiency resulted in partial sparing.
Fig. 6. Prolonged miR overexpression in the adult heart reduces fibrotic scar size but compromises cardiac function after MI. Prolonged miR
Fig. 5. miR p inhibits the translational initiation of CACNA1A IRES–driven α1ACT by eIF4AII and eIF4GII. miR p inhibits the translational initiation.
Fig. 2 PK dosing results. PK dosing results. (A) Plasma concentration of hPTH(1–34) versus time after release of 40-μg dose from implanted microchip device.
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation by Xin Xie, Hai-Lian Bi,
Fig. 6. Microglial phagocytosis and lysosomal uptake of Aβ induced by SUS treatment. Microglial phagocytosis and lysosomal uptake of Aβ induced by SUS.
Fig. 8. Purkinje cell quantification and hearing threshold in NPC cats administered IC HPβCD. Purkinje cell quantification and hearing threshold in NPC.
Fig. 5. Vascularization of human liver seed grafts.
Tissue architecture affects function of expanded liver seed grafts
Fig. 2 Neonatal ZIKV infection induces seizures in young mice and increases susceptibility to chemically induced seizures in adult mice. Neonatal ZIKV.
Fig. 4. HERV-K env expression and injury to lower motor neurons.
Fig. 3. HERV-K–induced neuronal toxicity in vivo.
Bio-AMS enhances the activity of rifampicin and ethambutol in vitro
Fig. 2. Human liver tissue seed grafts expand after host liver injury.
Fig. 4. miR promotes cardiomyocyte proliferation through regulation of Hippo pathway kinases. miR promotes cardiomyocyte proliferation through.
miR can promote cardiomyocyte proliferation in the adult heart
Fig. 2 Increasing KLF17, CDH1, and LASS2 expression reduced malignant progression and promoted apoptosis of tumor cells. Increasing KLF17, CDH1, and LASS2.
Fig. 5. High burdens of AA signature mutations and predicted immunogenicity in Taiwan HCCs. High burdens of AA signature mutations and predicted immunogenicity.
Fig. 3. miR overexpression leads to increased cell proliferation as well as altered differentiation and metabolism in cardiomyocytes. miR
Fig. 5 Clustering of the distal gut microbiome, the C
Fig. 4 Single-particle contact angle measurements.
Fig. 7. Altered morphology after ultrasound but unaltered numbers of microglia in SUS-treated mice. Altered morphology after ultrasound but unaltered numbers.
Fig. 2 Supraballs and films from binary SPs.
Fig. 3. Association between peak CTL019 expansion and response.
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Fig. 4 Characterization and SERS spectra of tetrameric metamolecules.
Fig. 4 Gallium increases P. aeruginosa sensitivity to peroxides.
Fig. 3 Ect2 gene inactivation lowers cardiomyocyte endowment and is lethal in mice. Ect2 gene inactivation lowers cardiomyocyte endowment and is lethal.
Fig. 6 Pharmacologic alterations of β-AR signaling regulate cardiomyocyte abscission and endowment. Pharmacologic alterations of β-AR signaling regulate.
Fig. 3 Postnatal assembly of the humanized gut microbiota.
Fig. 2. Cellular response to FolamiRs in vitro.
Fig. 2. SUS reduces Aβ plaques in an AD mouse model.
Fig. 6. Connectivity and mobility maps for Lesotho.
Presentation transcript:

Fig. 2. Overexpression of miR302-367 cluster in the developing heart results in increased cardiomyocyte proliferation and cardiomegaly. Overexpression of miR302-367 cluster in the developing heart results in increased cardiomyocyte proliferation and cardiomegaly. (A) At E18.5, Nkx2.5cre:R26R-miR302-367Tg/+ mutants have an enlarged heart with thickened ventricular myocardium and ventricular septal defects compared to Nkx2.5cre controls. (B) Cardiomegaly and increased cardiomyocyte proliferation in Nkx2.5cre:R26R-miR302-367Tg/+ mutant hearts at P20. (A and B) Immunostainings for PH3 and α-actinin and wheat germ agglutinin (WGA) show the number of mitotic cardiomyocytes. Scale bars, 100 μm. High-magnification reveals PH3+ cardiomyocytes. LA, left atrium. Data are means ± SEM (n = 3). P values determined by Student’s t test. Ying Tian et al., Sci Transl Med 2015;7:279ra38 Copyright © 2015, American Association for the Advancement of Science